Tempest Therapeutics, Inc.
TPST- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001544227
No open-market purchases or sales by Tempest Therapeutics, Inc. insiders were filed in the last 90 days; 21 institutions reported holding it in 13F filings for Q2 2026, worth $1.44M in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Tempest Therapeutics, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 0 | 24 | +24 |
| Shares | 0 | 1.84M | +1.84M |
| Value | $0 | $20.5M | +$20.5M |
New holders (24)
Institutions that held Tempest Therapeutics, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| FMR LLC | 647,898 | $7.24M | 0.00% |
| Rock Springs Capital Management LP | 310,161 | $3.47M | 0.07% |
| Foresite Capital Management IV, LLC | 190,212 | $2.13M | 0.29% |
| FIL Ltd | 129,579 | $1.45M | 0.00% |
| NEA Management Company, LLC | 117,785 | $1.32M | 0.02% |
| Monashee Investment Management LLC | 113,644 | $1.27M | 0.15% |
| Maven Securities LTD | 106,628 | $1.20M | 0.13% |
| Ikarian Capital, LLC | 89,865 | $1.00M | 0.18% |
| Vanguard Group Inc | 61,150 | $683.0K | 0.00% |
| Renaissance Technologies LLC | 26,867 | $300.0K | 0.00% |
| Knott David M | 13,833 | $155.0K | 0.06% |
| Boothbay Fund Management, LLC | 10,477 | $117.0K | 0.00% |
| Acadian Asset Management LLC | 8,643 | $96.0K | 0.00% |
| BlackRock Inc. | 4,919 | $55.0K | 0.00% |
| Bank of America Corp | 834 | $9.00K | 0.00% |
| Group One Trading, L.P. | 802 | $9.00K | 0.00% |
| Morgan Stanley | 726 | $8.00K | 0.00% |
| Tower Research Capital LLC (TRC) | 583 | $6.00K | 0.00% |
| Cutler Group LP | 333 | $3.00K | 0.00% |
| UBS Group AG | 147 | $2.00K | 0.00% |
| JPMorgan Chase & Co | 10 | $0 | 0.00% |
| Wells Fargo & Company | 8 | $0 | 0.00% |
| Baystate Wealth Management LLC | 5 | $0 | 0.00% |
| Atlas Private Wealth Advisors | 7 | $0 | 0.00% |
Sold out (0)
Institutions that held Tempest Therapeutics, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
None.